An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cue Health to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Cue Health (Nasdaq: HLTH) announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:40 p.m. Eastern Time, in New York, NY. The event will be accessible via a live audio webcast and can be replayed for 180 days on the company’s website. Cue Health focuses on providing accessible health information and diagnostics, including a notable at-home COVID-19 test with FDA approval. Founded in 2010, the company is headquartered in San Diego.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022 at 4:40 p.m. Eastern Time in New York, NY.
The live audio webcast and replay of the presentation may be accessed for 180 days on the “Investor Relations” section of the company’s website at: www.cuehealth.com.
About Cue Health Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India'sCentral Drugs Standard Control Organization, and PSAR authorization from Singapore'sHealth Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
When is Cue Health presenting at the Morgan Stanley Global Healthcare Conference?
Cue Health will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:40 p.m. Eastern Time.
Where can I access the Cue Health conference presentation?
The presentation can be accessed live and as a replay for 180 days on Cue Health's Investor Relations page at www.cuehealth.com.
What is the significance of Cue Health's COVID-19 test?
Cue Health's COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home use without a prescription and physician supervision.
What regulatory approvals has Cue Health received for its products?
Outside the United States, Cue Health has received CE mark approval in the EU, Interim Order authorization from Health Canada, and regulatory approval in India and Singapore.
Where is Cue Health headquartered?
Cue Health is headquartered in San Diego, California.
